StocksTelegraph
S&P 500NASDAQDOWRUSSELL
NASDAQ · ASTH·Healthcare

Astrana Health, Inc. Stock Analysis & AI Score

Market Open
$33.55
Prev Close
Market Cap
Day Range
52W Range
P/E
EPS (TTM)
Volume
Avg —
Beta
49
ST Score
49.2/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees
CEO
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date
Website
Country
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

ASTH
49.2out of 100
Grade C+

Astrana Health, Inc. (ASTH) holds an ST Score of 49.2 out of 100 (C+), with its strongest factor being Growth (A+) and its weakest Profitability (D+). Analysts rate ASTH Buy across 10 ratings with a $52.00 average price target (+0.5% vs the current $33.55).

Strongest
GrowthA+
Weakest
ProfitabilityD+
All factor grades
  • GrowthA+
  • ForecastB
  • MomentumC+
  • ValuationC-
  • Financial StrengthC-
  • ProfitabilityD+
  • Piotroski5/9
Score methodology
Press Releases

Contact

ASTH stock: frequently asked questions

What is ASTH's ST Score?

Astrana Health, Inc. (ASTH) has an ST Score of 49.2 out of 100, an overall grade of C+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is ASTH a buy, sell, or hold?

Wall Street's consensus rating on ASTH is Buy based on 10 analyst ratings. Our own ST Score grades it C+ (49.2/100). This is data, not investment advice — always do your own research.

What is ASTH's valuation grade?

Astrana Health, Inc. (ASTH) earns a valuation grade of C-, measured against Medical - Care Facilities peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is ASTH's growth grade?

Astrana Health, Inc. (ASTH) earns a growth grade of A+, measured against Medical - Care Facilities peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is ASTH's profitability grade?

Astrana Health, Inc. (ASTH) earns a profitability grade of D+, measured against Medical - Care Facilities peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is ASTH's financial strength grade?

Astrana Health, Inc. (ASTH) earns a financial strength grade of C-, measured against Medical - Care Facilities peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for ASTH?

The average analyst price target for Astrana Health, Inc. (ASTH) is $52.00 from 10 analysts, which is +0.5% versus the recent price of $33.55.

What is ASTH's Piotroski score?

Astrana Health, Inc. (ASTH) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.